Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/630 
Autor:innen: 
Erscheinungsjahr: 
1992
Quellenangabe: 
[Publisher:] Centre for Economic Policy Research (CEPR) [Place:] London [Year:] 1992
Schriftenreihe/Nr.: 
CEPR Discussion Paper Series, Centre for Economic Policy Research (CEPR), London No. 675
Verlag: 
Centre for Economic Policy Research (CEPR), London
Zusammenfassung: 
This paper develops a framework within which the impact of the proposed initiatives of the European Commission for creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage between two markets and price controls through governments in one market are introduced. The effects of easier arbitrage opportunities, i.e. lower arbitrage costs, on the prices in the two markets are analysed. Also, the impact of a reduction in price controls in the low-priced markets as well as their combined effects are characterized. The welfare effects of the Internal Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated markets does not lead to a first- or second-best solution.
JEL: 
O43
O60
F13
F15
Dokumentart: 
Working Paper
Dokumentversion: 
Digitized Version

Datei(en):
Datei
Größe
4.35 MB





Publikationen in EconStor sind urheberrechtlich geschützt.